Bransen Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in New Delhi, Delhi, India, established in 2023.

2023 New Delhi, Delhi, India Active

Last Updated: January 08, 2026

About Bransen Pharmaceuticals Private Limited

Bransen Pharmaceuticals Private Limited, a active private limited company, was established on 16 June 2023 in New Delhi, Delhi, India. it holds CIN: U46497DL2023PTC415702. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Manmohan Singh Negi (Director), Manju (Director). Past directors included Sarika Malhotra, Preeti Rani. Its latest AGM occurred on 14 October 2024, with the balance sheet filed on 31 March 2024. It is based at H.No - F-12/8 C,3Rd Floor, Joga Bai Extn Okhla, New Delhi, Delhi, 110025.

Company Details

CIN/LLPIN
U46497DL2023PTC415702
Registration Number
415702
Incorporation Date
16 June 2023
Authorized Capital
₹1.00 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.00 M as on 08-01-2026
Paid Up Capital ₹ 0.10 M as on 08-01-2026
Company Age 2 Year, 7 Months
Last Filing with ROC 31 Mar 2024

Comprehensive Company Insights

Explore comprehensive insights into Bransen Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Bransen Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Manmohan Singh Negi	Director	17 May 2024	Current
Manju	Director	16 Jun 2023	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	18 May 2024	Past
Pramod Abcsdd	Director	18 May 2024	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bransen Pharmaceuticals.

Enhance accessibility to Bransen Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bransen Pharmaceuticals?

Unlock access to Bransen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Bransen Pharmaceuticals?

Unlock and access historical data on people associated with Bransen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Bransen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bransen Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bransen Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

Bransen Pharmaceuticals Private Limited last Annual general meeting of members was held on 14 Oct 2024 as per latest MCA records. was recorded as a recent event.
14 Oct 2024
Director Appointment

Progress on Manmohan Singh Negi was appointed as a Director was appointed as a Director on 17 May 2024 & has been associated with this company since 1 year 8 months . was documented.
17 May 2024
Balance Sheet

Progress on Bransen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
31 Mar 2024
Director Appointment

Progress on Manju was appointed as a Director was appointed as a Director on 16 Jun 2023 & has been associated with this company since 2 years 7 months . was documented.
16 Jun 2023
Company Incorporation

Bransen Pharmaceuticals Private Limited was registered on 16 Jun 2023 with Roc Delhi & aged 2 years 7 months as per MCA records. was recorded as a recent event.
16 Jun 2023

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Bransen Pharmaceuticals Private Limited?

The CIN of Bransen Pharmaceuticals Private Limited is U46497DL2023PTC415702.

Where is Bransen Pharmaceuticals Private Limited headquartered?

Bransen Pharmaceuticals Private Limited is headquartered at H.No - F-12/8 C,3Rd Floor, Joga Bai Extn Okhla, New Delhi, Delhi, 110025.

When was Bransen Pharmaceuticals Private Limited incorporated?

Bransen Pharmaceuticals Private Limited was incorporated on 16 June 2023.

Who are the current directors of Bransen Pharmaceuticals Private Limited?

The current directors of Bransen Pharmaceuticals Private Limited are

Is Bransen Pharmaceuticals Private Limited a listed company?

Bransen Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Bransen Pharmaceuticals Private Limited?

The authorized capital of Bransen Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available